Major Mexican genetic study uncovers basis for health differences among Latinos

The most comprehensive genetic study of the Mexican population to date has revealed as much genetic differentiation as the variation between some Europeans and Asians.

The findings in the study, co-senior-authored by School faculty member Esteban Burchard, MD, MPH, and conducted with researchers at Stanford University and Mexico’s National Institute of Genomic Medicine, help to explain significant health differences among Latinos of Mexican descent, including rates of breast cancer and asthma as well as differing response to therapies.

The research, published in the June 13, 2014 issue of Science, provides the groundwork for developing more accurate and precise diagnostics—and possibly therapeutics—based on these genetic variations.

Burchard is a faculty member in the Department of Bioengineering and Therapeutic Sciences, a joint department of the UCSF Schools of Pharmacy and Medicine.



School of Pharmacy, Department of Bioengineering and Therapeutic Sciences, PharmD Degree Program, PSPG

About the School: The UCSF School of Pharmacy aims to solve the most pressing health care problems and strives to ensure that each patient receives the safest, most effective treatments. Our discoveries seed the development of novel therapies, and our researchers consistently lead the nation in NIH funding. The School’s doctor of pharmacy (PharmD) degree program, with its unique emphasis on scientific thinking, prepares students to be critical thinkers and leaders in their field.